According to AstraZeneca's latest financial reports the company's current EPS (TTM) is $2.50. In 2024 the company made an earnings per share (EPS) of $2.27 an increase over its 2023 EPS that were of $1.92.
Year | EPS | Change |
---|---|---|
2025 (TTM) | $2.50 | 10.35% |
2024 | $2.27 | 18.23% |
2023 | $1.92 | 81.13% |
2022 | $1.06 | 631.03% |
2021 | $0.14 | -88.11% |
2020 | $1.22 | 136.89% |
2019 | $0.51 | -39.41% |
2018 | $0.85 | -28.27% |
2017 | $1.18 | -14.37% |
2016 | $1.38 | 24.11% |
2015 | $1.12 | 127.55% |
2014 | $0.49 | -51.96% |
2013 | $1.02 | -58.95% |
2012 | $2.48 | -32.2% |
2011 | $3.66 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Bristol-Myers Squibb BMY | $2.68 | 6.99% | ๐บ๐ธ USA |
![]() Pfizer PFE | $1.39 | -44.51% | ๐บ๐ธ USA |
![]() Merck MRK | $6.90 | 175.34% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $1.56 | -37.73% | ๐ฌ๐ง UK |
![]() Sanofi SNY | $2.85 | 13.66% | ๐ซ๐ท France |
![]() Eli Lilly LLY | $12.36 | 393.25% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $9.07 | 261.98% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $7.79 | 210.85% | ๐บ๐ธ USA |
![]() Biogen BIIB | $10.16 | 305.59% | ๐บ๐ธ USA |
![]() Novartis NVS | $6.43 | 156.69% | ๐จ๐ญ Switzerland |